Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the chemical formula C21H35N5O3 and a molecular weight of approximately 405.54 g/mol[1][5]. It is known by the code name Y11 and DrugBank identifier DB08752[3][7]. The structure features a morpholine carboxamide core, substituted with a cyclohexylmethyl group and an aminopiperidine moiety bearing a cyano group. There are no approved medical indications, clinical trials, or regulatory approvals associated with this molecule as of now[4]. Its mechanism of action, biological targets, pharmacological activity, and therapeutic potential have not been described in public databases or literature to date. It is classified as an experimental research compound.
- Other names
- (2S)-N-(4-cyano-1-methylpiperidin-4-yl)-3-cyclohexyl-2-(morpholine-4-carbonylamino)propanamideN-{(2S)-1-[ (4-Cyano - 1-methyl - 4-piperidinyl ) amino ] - 3-cyclohexyl - 1 - oxo - 2-propanyl } - 4-morpholinecarboxamidePubChem CID 9887557
Beyond the preview
Go deeper on N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide.